Pharma Pulse 2/4/25: Analyzing Supply Chain Complexities, Navigating Medicare Advantage in 2025 & more

Analyzing Supply Chain Complexities

In the second part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Alex Guillen, global pharma and life sciences director at Tive, describes the highlights of a recent pharma supply chain security and visibility report that his company released.

Navigating Medicare Advantage in 2025: Strategies for Success Amid Uncertainty

2024 may go down as the high-water mark for Medicare Advantage. While the Medicare Advantage program continues to grow, the forces that drove that growth are under increasing scrutiny, with financial and regulatory pressures forcing payers to rethink their strategies.

What the Obesity Drugmakers Expect in 2025

Plus, the next AI winners and the chance of a TikTok sale.

Trump Imposes Trade Tariffs on Canada, Mexico, and China

What implications will these have on the pharma supply chain?

Pharmaceutical Executive on LinkedIn

Check out this exclusive interview with Casey McPherson, Founder and CEO of AlphaRose Therapeutics (formerly Chrysalis Genetics)!

Have news you want us to share in Pharma Pulse? Reach out to Editor Miranda Schmalfuhs